Siponimod ameliorates experimental autoimmune neuritis

Siponimod ameliorates experimental autoimmune neuritis

Abstract Background Guillain–Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are human autoimmune peripheral neuropathy. Besides humoral immunity, cellular immunity is also believed to contribute to these pathologies, especially CIDP. Sphingosine-1-phosphate recepto...

Full description

Bibliographic Details
Main Authors:	Takafumi Uchi, Shingo Konno, Hideo Kihara, Toshiki Fujioka
Format:	Article
Language:	English
Published:	BMC 2023-02-01
Series:	Journal of Neuroinflammation
Subjects:	Guillain–Barré syndrome Chronic inflammatory demyelinating polyneuropathy Experimental autoimmune neuritis Siponimod S1PR1 S1PR5
Online Access:	https://doi.org/10.1186/s12974-023-02706-z

Similar Items

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats
by: Jeremias Motte, et al.
Published: (2018-04-01)

Does Siponimod Exert Direct Effects in the Central Nervous System?
by: Markus Kipp
Published: (2020-07-01)

Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis
by: Anne K. Mausberg, et al.
Published: (2018-08-01)

A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man
by: Anna P. Patnaik, et al.
Published: (2021-02-01)

Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis
by: Felix Kohle, et al.
Published: (2023-06-01)

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis
by: Lei Bao, et al.
Published: (2003-02-01)

Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
by: Gary Álvarez Bravo, et al.
Published: (2022-06-01)

Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway
by: Lu Xu, et al.
Published: (2019-04-01)

Novel pathomechanisms in inflammatory neuropathies
by: David Schafflick, et al.
Published: (2017-11-01)

Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis
by: Pamela A. McCombe, et al.
Published: (2022-12-01)

The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain–Barré syndrome
by: Jiao H, et al.
Published: (2018-11-01)

M1 Macrophage Derived Exosomes Aggravate Experimental Autoimmune Neuritis via Modulating Th1 Response
by: Tong Du, et al.
Published: (2020-07-01)

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology
by: Cristina Gatcan, et al.
Published: (2023-12-01)

Guillain-Barré Syndrome During Active Brucellosis
by: Recep Aygul, et al.
Published: (2010-12-01)

Immune Modifying Effect of Drug Free Biodegradable Nanoparticles on Disease Course of Experimental Autoimmune Neuritis
by: Ehsan Elahi, et al.
Published: (2022-11-01)

Effect of Toll-like receptor 4 deficiency on clinical severity and expression of Th1/Th2/Th17-associated cytokines in a murine model of experimental autoimmune neuritis
by: Li-Juan Wang, et al.
Published: (2020-05-01)

LPA1 signaling drives Schwann cell dedifferentiation in experimental autoimmune neuritis
by: Fabian Szepanowski, et al.
Published: (2021-12-01)

Guillain-Barré syndrome: celebrating a century
by: Marcos R. G. de Freitas, et al.

Atypical Guillain-Barré in the Emergency Department
by: Sheridan, Josh M, et al.
Published: (2010-02-01)

Neurosyphilis presenting with Guillain–Barre syndrome: a case report
by: Hoameng Ung, et al.
Published: (2023-11-01)

A rare presentation of Guillain-Barre syndrome with GQ1b positivity: A case report
by: Minu George, et al.
Published: (2022-01-01)

Migraine, interferon β1a and siponimod immunomodulator therapies
by: Ashraf A. Dahaba, et al.
Published: (2022-04-01)

Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
by: Cheng-Yin Tan, et al.
Published: (2023-04-01)

Acute‐onset chronic inflammatory demyelinating polyneuropathy with cranial nerves and respiratory tract involvement: A case report
by: Malek Mansour, et al.
Published: (2020-11-01)

Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune Encephalomyelitis
by: Alicia Weier, et al.
Published: (2022-11-01)

Atypical optic neuritis – a case with a new surprise every visit
by: Kaur, Kirandeep, et al.
Published: (2020-02-01)

Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action
by: Newshan Behrangi, et al.
Published: (2019-01-01)

Macular edema after siponimod treatment for multiple sclerosis: a case report and literature review
by: Qingsheng Li, et al.
Published: (2023-07-01)

Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
by: Byunghyun Park, et al.
Published: (2023-06-01)

S1P/S1PR signaling pathway advancements in autoimmune diseases
by: Jianbin Li, et al.
Published: (2023-11-01)

High PR3-ANCA positivity in a patient with chronic inflammatory demyelinating polyneuropathy
by: Masanori Kurihara, et al.
Published: (2017-03-01)

Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay
by: Ivan Kmezic, et al.
Published: (2023-11-01)

A Missed Diagnosis of Guillain-Barre Syndrome Masquerading as Stroke in an Acute Medical Unit: A Case Report
by: Alpha Madu, et al.
Published: (2023-01-01)

Rodent Models of Optic Neuritis
by: Yael Redler, et al.
Published: (2020-11-01)

Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
by: Kensuke Senzaki, et al.
Published: (2021-06-01)

Anti-Ganglioside Antibody-Negative Miller Fisher and AMSAN Variant Guillain-Barré Overlap Syndrome
by: Prangsai Wattanasit, et al.
Published: (2020-02-01)

Dengue-induced Guillain–Barre syndrome: a case series
by: Hina Imtiaz, et al.
Published: (2023-11-01)

Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
by: Javadi Parvaneh V, et al.
Published: (2019-04-01)

B cells play a cooperative role via CD40L–CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats
by: Wei Zhu, et al.
Published: (2007-03-01)

Fingolimod ameliorates chronic experimental autoimmune neuritis by modulating inflammatory cytokines and Akt/mTOR/NF‐κB signaling
by: Yuan Feng, et al.
Published: (2023-04-01)